1. Home
  2. DXLG vs NEPH Comparison

DXLG vs NEPH Comparison

Compare DXLG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Destination XL Group Inc.

DXLG

Destination XL Group Inc.

HOLD

Current Price

$0.90

Market Cap

50.3M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.54

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXLG
NEPH
Founded
1976
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
60.0M
IPO Year
1987
2004

Fundamental Metrics

Financial Performance
Metric
DXLG
NEPH
Price
$0.90
$4.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.50
$6.00
AVG Volume (30 Days)
318.5K
49.3K
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$442,120,000.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
$3.24
$12.27
P/E Ratio
N/A
$31.54
Revenue Growth
N/A
32.36
52 Week Low
$0.83
$1.39
52 Week High
$3.10
$6.42

Technical Indicators

Market Signals
Indicator
DXLG
NEPH
Relative Strength Index (RSI) 42.04 40.09
Support Level $0.88 $4.18
Resistance Level $0.95 $5.46
Average True Range (ATR) 0.06 0.30
MACD -0.00 -0.06
Stochastic Oscillator 4.96 14.06

Price Performance

Historical Comparison
DXLG
NEPH

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: